Erythrocyte-binding therapeutics

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12060414
APP PUB NO 20210079077A1
SERIAL NO

17011321

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or fragments thereof that provide specific binding, to erythrocytes. The peptides may be prepared as molecular fusions with therapeutic agents, tolerizing antigens, or targeting peptides. Immunotolerance may be created by use of the fusions and choice of an antigen on a substance for which tolerance is desired.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dane, Karen Y Auburn, US 19 304
Hubbell, Jeffrey A Chicago, US 173 9467
Kontos, Stephan Boston, US 20 193

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 13, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 13, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00